Open Text Corporation:企業の戦略・SWOT・財務分析

◆英語タイトル:Open Text Corporation - Strategy, SWOT and Corporate Finance Report
◆商品コード:SWOT20MY4107
◆発行会社(調査会社):MarketLine
◆発行日:2020年2月
◆ページ数:59
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:カナダ
◆産業分野:Technology and Services
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD175 ⇒換算¥25,900見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD350 ⇒換算¥51,800見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD525 ⇒換算¥77,700見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はMarketLine社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
MarketLine社の概要はこちらでご確認いただけます。



【レポートの概要】

Open Text Corporation – Strategy, SWOT and Corporate Finance Report
Summary

Open Text Corporation – Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company’s structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company.

Key Highlights

Open Text Corporation (Open Text) is a developer and provider of enterprise information management (EIM) software solutions and products. The company offers enterprise software solutions to government and business enterprises. It also provides consulting and learning services, customer support and cloud services. The company serves to various industries, including, public sector, utilities, banking, healthcare, insurance, legal, life sciences, industrial manufacturing, automotive, chemical, retail, aerospace, defense and intelligence, telecommunications, travel and transportation, professional services, media and entertainment, engineering, construction and consumer goods. Open Text has business presence across the Americas, Europe, the Middle East and Africa (EMEA) and Asia-Pacific. The company is headquartered in Waterloo, Ontario, Canada.

Scope

- Detailed information on Open Text Corporation required for business and competitor intelligence needs
- A study of the major internal and external factors affecting Open Text Corporation in the form of a SWOT analysis
- An in-depth view of the business model of Open Text Corporation including a breakdown and examination of key business segments
- Intelligence on Open Text Corporation’s mergers and acquisitions (MandA), strategic partnerships and alliances, capital raising, private equity transactions, and financial and legal advisors
- News about Open Text Corporation, such as business expansion, restructuring, and contract wins
- Large number of easy-to-grasp charts and graphs that present important data and key trends

Reasons to buy

- Gain understanding of Open Text Corporation and the factors that influence its strategies.
- Track strategic initiatives of the company and latest corporate news and actions.
- Assess Open Text Corporation as a prospective partner, vendor or supplier.
- Support sales activities by understanding your customers’ businesses better.
- Stay up to date on Open Text Corporation’s business structure, strategy and prospects.

【レポートの目次】

Table of Contents
Company Snapshot
Table of Contents
Open Text Corporation: Company Overview
Open Text Corporation: Overview and Key Facts
Open Text Corporation: Overview
Open Text Corporation: Key Facts
Open Text Corporation: Key Employees
Open Text Corporation: Key Employee Biographies
Open Text Corporation: Major Products and Services
Open Text Corporation: Company History
Open Text Corporation: Management Statement
Open Text Corporation: Locations and Subsidiaries
Open Text Corporation: Key Competitors
Open Text Corporation: Company Analysis
Open Text Corporation: Business Description
Open Text Corporation: SWOT Analysis
Open Text Corporation: SWOT Overview
Open Text Corporation: Strengths
Open Text Corporation: Weaknesses
Open Text Corporation: Opportunities
Open Text Corporation: Threats
Open Text Corporation: Corporate Financial Deals Activity
Open Text Corporation: Financial Deals Overview
Open Text Corporation: Targets and Partners
Open Text Corporation: Top Deals 2016 – 2020YTD*
Open Text Corporation: Advisors
Open Text Corporation: Top Legal Advisors
Open Text Corporation: Top Financial Advisors
Open Text Corporation: Mergers and Acquisitions
Open Text Corporation: Capital Raising
Open Text Corporation: Recent Developments
Open Text Corporation: News and Events Summary
Open Text Corporation: Business Expansion
Open Text Corporation: Contracts
Open Text Corporation: Corporate Governance
Open Text Corporation: Market Developments
Open Text Corporation: Strategy and Operations
Appendix
Contact Us
Methodology
About MarketLine

List of Tables
Table 1: Open Text Corporation: Key Facts
Table 2: Open Text Corporation: Key Employees
Table 3: Open Text Corporation: Company History
Table 4: Open Text Corporation: Locations and Subsidiaries
Table 5: Open Text Corporation: Key Competitors
Table 6: Open Text Corporation: Deal Activity by Deal Type - Volume (TTM*)
Table 7: Open Text Corporation: M&A Activity by Geography (TTM*)
Table 8: Open Text Corporation: Deal Activity by Deal Type - Volume (2016 - YTD*2020)
Table 9: Open Text Corporation: M&A Average Deal Size - Value (US$m)
Table 10: Open Text Corporation: Targets and Partners
Table 11: Open Text Corporation: Top Deals 2016 - 2020YTD*
Table 12: Open Text Corporation: Legal Advisor Ranking by Value (US$m)
Table 13: Open Text Corporation: Financial Advisor Ranking by Value (US$m)
Table 14: Open Text Corporation: M&A Volume and Value Trend (2016 - YTD*2020)
Table 15: Open Text Corporation: M&A Activity by Geography (2016 - YTD*2020)
Table 16: Open Text Corporation: Capital Raising Volume and Value Trend (2016 - YTD*2020)
Table 17: Open Text Corporation: Capital Raising by Deal Type (2016 - YTD*2020)
Table 18: Open Text Corporation: News and Events Summary
Table 19: Open Text Corporation: Business Expansion
Table 20: Open Text Corporation: Contracts
Table 21: Open Text Corporation: Corporate Governance
Table 22: Open Text Corporation: Market Developments
Table 23: Open Text Corporation: Strategy and Operations

★海外企業調査レポート[Open Text Corporation:企業の戦略・SWOT・財務分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • SoftBank Group Corporation:企業のM&A・事業提携・投資動向
    SoftBank Group Corporation - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's SoftBank Group Corporation Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acqui …
  • CJ HealthCare Corp:製薬・医療:M&Aディール及び事業提携情報
    Summary CJ HealthCare Corp (CJ HealthCare), a subsidiary CJ CheilJedang Corp, is a provider of active pharmaceutical ingredients, OTC drugs and pharmaceutical medicines. The company’s portfolio includes biologicals, antibiotics, anti cancer, parenteral nutrition, total parenteral nutrition products. …
  • Shanxi Zhendong Pharmaceutical Co Ltd (300158):製薬・医療:M&Aディール及び事業提携情報
    Summary Shanxi Zhendong Pharmaceutical Co Ltd (Zhendong Group) is a pharmaceutical company. The company researches, develops, manufactures and markets pharmaceutical products and Chinese medicines in China. It offers products such as cancer drugs, cardiovascular drugs, infectious disease drugs, resp …
  • Unity Bank Plc:企業の戦略・SWOT・財務情報
    Unity Bank Plc - Strategy, SWOT and Corporate Finance Report Summary Unity Bank Plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpora …
  • ProThera Biologics Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary ProThera Biologics Inc (ProThera), formerly ProThera Biologics LLC is a biotherapeutics company that develops novel products based on Inter-alpha Inhibitor Proteins. The company offers development of commercial potential of IAIP for treating acute, life-threatening inflammatory diseases. Pro …
  • Quark Pharmaceuticals Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Quark Pharmaceuticals Inc (Quark), a subsidiary of SBI Biotech Co Ltd, is a clinical-stage pharmaceutical company in the development of novel RNAi-based therapeutics. It offers under development products which include PF-655, a synthetic siRNA which is used for the treatment of diabetic macu …
  • Sanmina Corporation (SANM):企業の財務・戦略的SWOT分析
    Sanmina Corporation (SANM) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesse …
  • Shinhan Bank:企業の戦略・SWOT・財務分析
    Shinhan Bank - Strategy, SWOT and Corporate Finance Report Summary Shinhan Bank - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate a …
  • BKW AG:企業の戦略・SWOT・財務分析
    BKW AG - Strategy, SWOT and Corporate Finance Report Summary BKW AG - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, prov …
  • Semiconductor Manufacturing International Corporation:企業の戦略・SWOT・財務分析
    Semiconductor Manufacturing International Corporation - Strategy, SWOT and Corporate Finance Report Summary Semiconductor Manufacturing International Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's …
  • CellSeed Inc (7776):企業の財務・戦略的SWOT分析
    Summary CellSeed Inc (CellSeed) is a developer of regenerative medicine. The company’s products include epithelial cell sheet for corneal regeneration, regenerated cardiac patch, epithelial cell sheet for esophageal regeneration, cell sheet for periodontal tissue regeneration and regenerated cartila …
  • Tesaro Inc (TSRO)-製薬・医療分野:企業M&A・提携分析
    Summary Tesaro Inc (Tesaro) is an oncology-focused biopharmaceutical company that focuses on developing in-licensed, oncology-related product candidates, comprising rolapitant, niraparib, and the product candidates under its immuno-oncology platform. VARUBI, the company’s first commercial product is …
  • West Pharmaceutical Services Inc (WST):企業の財務・戦略的SWOT分析
    West Pharmaceutical Services Inc (WST) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths a …
  • GammaDelta Therapeutics Ltd:製薬・医療:M&Aディール及び事業提携情報
    Summary GammaDelta Therapeutics Ltd (GammaDelta Therapeutics) is an immunotherapy company that develops immunotherapies for cancer and other immune related diseases. The company conducts research and development focused on exploiting tissue resident gamma delta T cells, which are conserved populatio …
  • Castle Biosciences Inc:医療機器:M&Aディール及び事業提携情報
    Summary Castle Biosciences Inc (Castle Biosciences) is a drug development company that develops and commercializes diagnostic and prognostic tests for cancers. The company offers tests for cutaneous melanoma, uveal melanoma and glioblastoma multiforme. Its DecisionDx-melanoma identifies stage I or I …
  • COWI AS:企業の戦略的SWOT分析
    COWI AS - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. This …
  • Sligro Food Group N.V.:戦略・SWOT・企業財務分析
    Sligro Food Group N.V. - Strategy, SWOT and Corporate Finance Report Summary Sligro Food Group N.V. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • Newcastle University-製薬・医療分野:企業M&A・提携分析
    Summary Newcastle University (NU) is an educational university that offers teaching and research services. The university provides teaching and study services including postgraduate study, undergraduate study, and campus services. It offers teaching services in areas of accounting and finance; agri- …
  • Ingram Micro Inc.:企業のM&A・事業提携・投資動向
    Ingram Micro Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Ingram Micro Inc. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), div …
  • BrainStorm Cell Therapeutics Inc (BCLI):企業の財務・戦略的SWOT分析
    Summary BrainStorm Cell Therapeutics Inc (BrainStorm Cell Therapeutics) formerly Golden Hand Resources Inc is a biotechnology company which develops autologous stem cell therapies for neurodegenerative diseases. Its pipeline mesenchymal stem cell products are being developed based on cell therapy pl …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆